What anesthetic precautions are recommended for patients of Venezuelan ancestry, considering possible sickle‑cell disease/trait, glucose‑6‑phosphate dehydrogenase deficiency, pseudocholinesterase deficiency, and higher prevalence of hypertension, diabetes, and obesity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Anesthetic Precautions for Patients of Venezuelan Ancestry

Screen all patients of Venezuelan ancestry for sickle cell disease/trait preoperatively, as this is the single most critical anesthetic consideration that can significantly impact morbidity and mortality if unrecognized. 1

Pre-operative Screening and Assessment

Mandatory Hemoglobinopathy Screening

  • All patients of Venezuelan ancestry should undergo pre-operative hemoglobinopathy screening to identify sickle cell disease or trait, as Venezuela has populations with African, Mediterranean, and Middle Eastern ancestry where these conditions are prevalent 1
  • Avoid unnecessary repeat screening if recent results are available 1
  • Document baseline hemoglobin type, HbS percentage, and baseline oxygen saturation 1

Additional Enzyme Deficiency Screening

  • Screen for glucose-6-phosphate dehydrogenase (G6PD) deficiency, particularly given the geographic distribution overlapping with Venezuelan ancestry 2, 3
  • Consider pseudocholinesterase deficiency testing if family history suggests prolonged neuromuscular blockade 1

Cardiovascular and Metabolic Assessment

  • Evaluate for hypertension, diabetes, and obesity given higher prevalence in this population 4
  • Document end-organ dysfunction affecting cardiovascular, pulmonary, renal, and neurological systems if sickle cell disease is present 1

Intra-operative Management for Sickle Cell Disease

Anesthetic Technique Selection

  • Regional anesthesia (spinal or epidural) may reduce sickle-related complications compared to general anesthesia due to excellent postoperative analgesia and improved peripheral blood flow from sympathetic blockade 1
  • If regional anesthesia is used, treat hypotension early and aggressively with vasopressors and IV fluids to prevent hypoperfusion 1
  • For male patients receiving regional anesthesia, counsel about priapism risk and examine regularly, as altered sensation may prevent detection 1

Critical Physiological Parameters to Maintain

Avoid the five key triggers of sickling:

  • Hypoxia: Pre-oxygenate before induction; maintain SpO2 >96% or above baseline (whichever is higher) for 24 hours postoperatively 1
  • Dehydration: Encourage clear fluids up to 1-2 hours preoperatively; start IV fluids early if oral intake inadequate; measure and replace all fluid losses meticulously 1
  • Hypothermia: Maintain normothermia throughout the perioperative period 1, 4
  • Acidosis: Use controlled ventilation to achieve normocarbia if intubated 1
  • Hypotension: Avoid and treat promptly 1

Monitoring Requirements

  • Standard ASA monitoring plus neuromuscular monitoring if neuromuscular blocking drugs are used—ensure complete reversal before extubation 1
  • Consider near-infrared spectroscopy for cerebral oxygenation monitoring 1
  • Monitor urine output; consider central venous pressure and cardiac output monitoring for major surgery 1

Scheduling and Timing

  • Schedule early in the operating day to minimize fasting time and avoid prolonged starvation, which increases dehydration risk 1
  • Postpone elective surgery if patient is febrile or experiencing a painful crisis 1

G6PD Deficiency Considerations

Safe Anesthetic Agents

  • Benzodiazepines, propofol, fentanyl, ketamine, sevoflurane, and codeine/codeine derivatives are safe and do not cause hemolytic crises in G6PD-deficient patients 3, 5
  • Avoid oxidative stressors including certain medications that can trigger hemolysis 2, 3

Perioperative Monitoring

  • Monitor for signs of hemolysis: jaundice, dark urine, falling hemoglobin, elevated bilirubin 3, 5
  • Minimize surgical stress and hypothermia, which can trigger hemolysis 5

Pain Management Strategy

Multimodal Analgesia Planning

  • Document baseline opioid use and continue long-acting opioids throughout the perioperative period 1
  • Note that opioid sensitivity is more common than opioid dependency in sickle cell patients 1
  • Implement multimodal techniques: regional blocks, patient-controlled analgesia, nurse-controlled analgesia, and oral analgesics 1
  • Notify the acute pain team preoperatively for major surgery 1
  • Encourage patients to report pain similar to their usual sickle pain (distinct from surgical pain) 1

Multidisciplinary Coordination

Essential Team Communication

  • Inform the haematology team when any patient with sickle cell disease requires surgery (emergency or elective) 1
  • Communicate with the transfusion laboratory regarding potential transfusion needs 1
  • Document sickle cell diagnosis clearly throughout the patient pathway 1

Postoperative Care

  • Maintain a low threshold for high dependency or intensive care unit admission based on surgical risk and comorbidities 1
  • Continue IV fluids until adequate oral intake is established 1
  • Continue oxygen therapy to maintain SpO2 >96% or above baseline for 24 hours 1
  • Encourage early mobilization and physiotherapy 1

Common Pitfalls to Avoid

  • Do not prolong fasting unnecessarily—this is a common scenario leading to dehydration 1
  • Do not give continuous oxygen therapy unless necessary preoperatively, but do pre-oxygenate before induction 1
  • Do not use epinephrine in local anesthesia for G6PD-deficient patients according to some sources 6
  • Do not discharge day surgery patients until standard criteria are met, and schedule them early to allow time for complication identification 1

Related Questions

What are the safe anesthetic and medication considerations for a patient with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency undergoing a dental procedure?
Is Bromhexine safe in patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency?
Can benzodiazepines (benzos) trigger hemolysis in patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency?
Can butamirate be given to a patient with Glucose-6-phosphate dehydrogenase (G6PD) deficiency?
What are the anesthetic considerations for a patient with glucose‑6‑phosphate dehydrogenase (G6PD) deficiency?
What should I do about worsening insomnia after tapering amitriptyline from 10 mg to 7.5 mg, given that increasing back to 10 mg made me feel worse?
What is the appropriate paracetamol (acetaminophen) dose for a 2‑year‑old child?
Is it safe to prescribe oral trypsin‑chymotrypsin for a patient with a serum creatinine of 3.1 mg/dL, and what dosage should be used?
What precautions and management should be taken for Venezuelan children who experience delayed awakening after anesthesia?
What pharmacologic and psychosocial strategies should be used to treat persistent anhedonia, low motivation, and residual depressive‑anxious symptoms in a patient who discontinued all antidepressants (including escitalopram) after 9–12 months of treatment?
What is the recommended Botox (onabotulinumtoxinA) injection protocol for treating primary axillary hyperhidrosis in an adult patient who has not responded to topical antiperspirants?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.